• search hit 2 of 14
Back to Result List

Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020

Please always quote using this URN: urn:nbn:de:bvb:20-opus-259396
  • Background and purpose The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany. Methods In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A surveyBackground and purpose The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany. Methods In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted. Results Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care. Conclusions Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Christoph Vollmuth, Olga Muljukov, Mazen Abu-Mugheisib, Anselm Angermeier, Jessica Barlinn, Loraine Busetto, Armin J. Grau, Albrecht Günther, Christoph Gumbinger, Nikolai Hubert, Katrin Hüttemann, Carsten Klingner, Markus Naumann, Frederick Palm, Jan Remi, Viktoria Rücker, Joachim Schessl, Felix Schlachetzki, Ramona Schuppner, Stefan Schwab, Andreas Schwartz, Adrian Trommer, Christian Urbanek, Bastian Volbers, Joachim Weber, Claudia Wojciechowski, Hans Worthmann, Philipp Zickler, Peter U. Heuschmann, Karl Georg Haeusler, Gordian Jan Hubert
URN:urn:nbn:de:bvb:20-opus-259396
Document Type:Journal article
Faculties:Medizinische Fakultät / Institut für Klinische Neurobiologie
Medizinische Fakultät / Institut für Klinische Epidemiologie und Biometrie
Language:English
Parent Title (English):European Journal of Neurology
Year of Completion:2021
Volume:28
Issue:10
Pagenumber:3267–3278
Source:European Journal of Neurology 2021, 28(10):3267–3278. DOI: 10.1111/ene.14787
DOI:https://doi.org/10.1111/ene.14787
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:COVID-19; SARS-CoV- 2; stroke; survey; telemedicine
Release Date:2022/03/25
Licence (German):License LogoCC BY-NC-ND: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell, Keine Bearbeitungen 4.0 International